{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0030154",
      "entity_text" : "differentiation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P09919",
      "entity_text" : "G-CSF",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Supporting that hypothesis, treatment with G-CSF has been reported to increase or normalize the neutrophil counts in CD40L deficiency.6 However, seven days of treatment with a standard dosage of G-CSF did not affect our patient 's neutropenia but instead markedly increased his peripheral eosinophil concentration, indicating that the G-CSF levels were sufficient to induce myelopoietic lineage differentiation.",
  "reading_complete" : "2020-08-03T13:11:53Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:10:15Z",
  "trigger" : "induce",
  "evidence" : [ "G-CSF levels were sufficient to induce myelopoietic lineage differentiation" ],
  "pmc_id" : "7044354",
  "score" : 0
}